In the first People Pathways edition of the year, we are thrilled to bring you our 4th annual Building Life Sciences Adventures (BLSA) Conference and wanted to share a glimpse of the exiting journey that lies ahead. Click here to read about:✳ Top 5 reasons why you should sponsor BLSA...✳ New funding for employers to support with offering industry placements...✳ Upcoming training and events...
Excitement is in the air as we approach our Annual Awards Dinner on 21 March 2024, at stunning London venue, No.11 Cavendish Square.
Get your nominations in and be part of an evening that recognises and celebrates the success of our community. Remember, you have the opportunity to nominate either your own company or a company you've worked with to acknowledge their exceptional performance. Entries close on 7 February.
Catergories
Primary R&D Company - Sponsored by BMG LABTECH
Investor
Provider
Technology Transfer Office
Professional Services Company
Facilities Provider
Non-…
Chesterford Research Park, set in over 250 acres of idyllic countryside, makes business meetings an unexpected pleasure, training and team building exercises a talking point and even the simplest of functions memorable.
Whatever the reason for your visit, you will soon discover that The Nucleus is the ideal conference venue for training, seminars, product launches, boardroom meetings, interviews, team building, and brainstorming events as well as small exhibitions. All of our meeting rooms are complete with air-conditioning, floor to ceiling windows for maximum natural light, spectacular…
Mayer Schreiber, CEO of Discovery Park, and Chris Broom, Head of Business Development at Discovery Park, recently attended the JP Morgan Healthcare Conference in San Francisco to build global connections and raise awareness of the opportunities in the UK for the biotech industry, as well as exploring opportunities for Discovery Park Ventures and its portfolio companies. The conference brought together thousands of industry experts from across the globe to discuss the biggest challenges and opportunities for 2024 and beyond.
The outlook from the conference for 2024 was cautious optimism,…
MedFlow Clinical: Revolutionising Clinical Trial Supply Management
In the world of clinical trials, MedFlow Clinical is changing what is possible for both CROs and pharmaceutical companies. How? By addressing critical gaps in supply chain, by providing world-class logistical and clinical supply management support, and by making the most challenging regions newly accessible.
Twin Expertise in Clinical and Logistical Domains
At the core of MedFlow Clinical's success is its unique blend of clinical acumen and logistical prowess. Co-founder Chris Smith emphasizes, "What sets us apart is how we…
Cambridge, UK, 18 January 2024: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, is pleased to announce that the European Patent Office has granted a patent (EP3618840) protecting novel formulations of the Group’s proprietary insulin products, AT278 and AT247. The European patent adds to a comprehensive global intellectual property (IP) portfolio protecting the Group’s novel insulin products and follows additional patents of similar scope recently granted in Australia, India and Mexico.
Jan Jezek, Chief…
Specialist preclinical contract research organisation (CRO) Cellomatics Biosciences has heralded the start of its next successful phase with four promotions and eight new arrivals.
Dr Shailendra Singh, CEO of Cellomatics Biosciences, comments: “Capitalising on our existing strengths and internal team expertise, we intend to further consolidate our position as a specialist biology CRO by broadening and deepening our service offerings in 2024. With these new appointments and internal restructuring, we are poised to catapult ourselves to the next phase of our growth journey.”
Cellomatics is…
Check out the Bristows Biotech Review of the Year. This report reflects on the key developments in the biotech industry, including:
Legal updates
Generative AI
The Unified Patent Court
CRISPR technology
Predictions for 2024
READ NOW
Creative Places enters new era with the appointment of new partner and the retirement of co-founder
Seb Denby is promoted to Partner as co-founder Jonathan Burroughs retires
16th January 2024: Creative Places, a leading R&D real estate advisor, announces the promotion of Seb Denby to Partner and the retirement of its co-founder and former CEO, Jonathan Burroughs.
Based in Cambridge, Creative Places’ award-winning team excels in advising clients on how to develop and invest in locations that can become ‘value add’ places to all that use them.
The strategic…
Sandwich, Kent, UK, 17th January 2023 / Sciad Newswire / Discovery Park Ventures (DPV) announces an investment of £100K into Vox Imaging Technology Ltd. (VIT), an ambitious ophthalmic technology company looking to transform eye imaging in preclinical research and improve drug discovery and development. Its compact and customisable instrument is believed to be the first scanning laser ophthalmoscope especially designed for laboratory use, able to produce high-quality data rapidly. Vox Imaging is the eighth investment from DPV’s first fund.
Prevalence of diseases of the eye (such as age-…